rs187389813
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the c.854-32A>C variant in the PTPN11 gene is 15.2% for Latino chromosomes by the Exome Aggregation Consortium (1824/11514 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA215447/MONDO:0021060/004
Frequency
Consequence
NM_002834.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00857 AC: 1302AN: 151866Hom.: 71 Cov.: 32
GnomAD3 exomes AF: 0.0204 AC: 5120AN: 251128Hom.: 410 AF XY: 0.0149 AC XY: 2024AN XY: 135720
GnomAD4 exome AF: 0.00446 AC: 6220AN: 1395898Hom.: 492 Cov.: 27 AF XY: 0.00359 AC XY: 2510AN XY: 698430
GnomAD4 genome AF: 0.00861 AC: 1309AN: 151984Hom.: 71 Cov.: 32 AF XY: 0.00993 AC XY: 738AN XY: 74286
ClinVar
Submissions by phenotype
not specified Benign:2
- -
- -
not provided Benign:2
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Noonan syndrome Benign:1
- -
RASopathy Benign:1
The filtering allele frequency of the c.854-32A>C variant in the PTPN11 gene is 15.2% for Latino chromosomes by the Exome Aggregation Consortium (1824/11514 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at